Skip to main content
Top
Published in: Medical Microbiology and Immunology 2/2020

01-04-2020 | Colorectal Cancer | Original Investigation

Human endogenous retroviruses env gene expression and long terminal repeat methylation in colorectal cancer patients

Authors: Maria Dolci, Chiara Favero, Letizia Tarantini, Sonia Villani, Marco Bregni, Lucia Signorini, Alberto Della Valle, Filippo Crivelli, Sarah D’Alessandro, Pasquale Ferrante, Valentina Bollati, Serena Delbue

Published in: Medical Microbiology and Immunology | Issue 2/2020

Login to get access

Abstract

Human endogenous retroviruses (HERV) are remnants of exogenous retroviral infections, representing 8% of the human genome. Their regulation is based on the DNA methylation of promoters, the long terminal repeats (LTRs). Transcripts from HERV have been associated with cancers, but reports concerning HERV expression in colorectal cancer remain sporadic. Sixty-three patients with advanced stages of colorectal cancer were enrolled in this study. The expressions of HERV env gene, and HERV-H, -K, -R and -P LTRs and Alu, LINE-1 methylation levels, were investigated in the tumor, normal adjacent tissues, and, where possible, blood and plasmatic extracellular vesicles (EVs). Associations among HERV env expression, methylation status and clinical characteristics were evaluated. No differences were observed in HERV env gene expression levels among the clinical specimens, while Alu, LINE-1, HERV-H and -K LTRs were demethylated in the tumor compared to the normal adjacent tissues (p < 0.05).The HERV env gene was expressed in the EVs at of 54% (-H), 38% (-K), 31% (-R) patients. Association was not found between HERV env expression and LTR methylation, but significant higher expression of HERV-P and -R env was found in tumor tissues arising from the right colon. Our findings do not demonstrate significant overexpression of the studied HERV in colorectal cancer, but their association with tumor localization and specificity of the changes in DNA methylation of retroelements are shown. HERV sequences were packaged in the EVs and might be transferred from one cell to another.
Appendix
Available only for authorised users
Literature
1.
go back to reference Liang Q, Ding J, Xu R, Xu Z, Zheng S (2009) Identification of a novel human endogenous retrovirus and promoter activity of its 5′ U3. Biochem Biophys Res Commun 382:468–472PubMed Liang Q, Ding J, Xu R, Xu Z, Zheng S (2009) Identification of a novel human endogenous retrovirus and promoter activity of its 5′ U3. Biochem Biophys Res Commun 382:468–472PubMed
2.
go back to reference Bannert N, Kurth R (2006) The evolutionary dynamics of human endogenous retroviral families. Annu Rev Genom Hum Genet 7:149–173 Bannert N, Kurth R (2006) The evolutionary dynamics of human endogenous retroviral families. Annu Rev Genom Hum Genet 7:149–173
3.
go back to reference Yu HL, Zhao ZK, Zhu F (2013) The role of human endogenous retroviral long terminal repeat sequences in human cancer (review). Int J Mol Med 32:755–762PubMed Yu HL, Zhao ZK, Zhu F (2013) The role of human endogenous retroviral long terminal repeat sequences in human cancer (review). Int J Mol Med 32:755–762PubMed
4.
go back to reference Villesen P, Aagaard L, Wiuf C, Pedersen FS (2004) Identification of endogenous retroviral reading frames in the human genome. Retrovirology 1:32PubMedPubMedCentral Villesen P, Aagaard L, Wiuf C, Pedersen FS (2004) Identification of endogenous retroviral reading frames in the human genome. Retrovirology 1:32PubMedPubMedCentral
5.
go back to reference Bénit L, Dessen P, Heidmann T (2001) Identification, phylogeny, and evolution of retroviral elements based on their envelope genes. J Virol 75:11709–11719PubMedPubMedCentral Bénit L, Dessen P, Heidmann T (2001) Identification, phylogeny, and evolution of retroviral elements based on their envelope genes. J Virol 75:11709–11719PubMedPubMedCentral
6.
go back to reference Ruprecht K, Mayer J, Sauter M, Roemer K, Mueller-Lantzsch N (2008) Endogenous retroviruses and cancer. Cell Mol Life Sci 65:3366–3382PubMed Ruprecht K, Mayer J, Sauter M, Roemer K, Mueller-Lantzsch N (2008) Endogenous retroviruses and cancer. Cell Mol Life Sci 65:3366–3382PubMed
7.
go back to reference Schmitt K, Reichrath J, Roesch A, Meese E, Mayer J (2013) Transcriptional profiling of human endogenous retrovirus group HERV-K(HML-2) loci in melanoma. Genome Biol Evol 5:307–328PubMedPubMedCentral Schmitt K, Reichrath J, Roesch A, Meese E, Mayer J (2013) Transcriptional profiling of human endogenous retrovirus group HERV-K(HML-2) loci in melanoma. Genome Biol Evol 5:307–328PubMedPubMedCentral
8.
go back to reference Wang-Johanning F, Li M, Esteva FJ, Hess KR, Yin B, Rycaj K, Plummer JB, Garza JG, Ambs S, Johanning GL (2014) Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer. Int J Cancer 134:587–595PubMed Wang-Johanning F, Li M, Esteva FJ, Hess KR, Yin B, Rycaj K, Plummer JB, Garza JG, Ambs S, Johanning GL (2014) Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer. Int J Cancer 134:587–595PubMed
9.
go back to reference Wallace TA, Downey RF, Seufert CJ, Schetter A, Dorsey TH, Johnson CA, Goldman R, Loffredo CA, Yan P, Sullivan FJ, Giles FJ, Wang-Johanning F, Ambs S, Glynn SA (2014) Elevated HERV-K mRNA expression in PBMC is associated with a prostate cancer diagnosis particularly in older men and smokers. Carcinogenesis 35:2074–2083PubMedPubMedCentral Wallace TA, Downey RF, Seufert CJ, Schetter A, Dorsey TH, Johnson CA, Goldman R, Loffredo CA, Yan P, Sullivan FJ, Giles FJ, Wang-Johanning F, Ambs S, Glynn SA (2014) Elevated HERV-K mRNA expression in PBMC is associated with a prostate cancer diagnosis particularly in older men and smokers. Carcinogenesis 35:2074–2083PubMedPubMedCentral
10.
go back to reference Reis BS, Jungbluth AA, Frosina D, Holz M, Ritter E, Nakayama E, Ishida T, Obata Y, Carver B, Scher H, Scardino PT, Slovin S, Subudhi SK, Reuter VE, Savage C, Allison JP, Melamed J, Jäger E, Ritter G, Old LJ, Gnjatic S (2013) Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein. Clin Cancer Res 19:6112–6125PubMed Reis BS, Jungbluth AA, Frosina D, Holz M, Ritter E, Nakayama E, Ishida T, Obata Y, Carver B, Scher H, Scardino PT, Slovin S, Subudhi SK, Reuter VE, Savage C, Allison JP, Melamed J, Jäger E, Ritter G, Old LJ, Gnjatic S (2013) Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein. Clin Cancer Res 19:6112–6125PubMed
11.
go back to reference Haupt S, Tisdale M, Vincendeau M, Clements MA, Gauthier DT, Lance R, Semmes OJ, Turqueti-Neves A, Noessner E, Leib-Mösch C, Greenwood AD (2011) Human endogenous retrovirus transcription profiles of the kidney and kidney-derived cell lines. J Gen Virol 92:2356–2366PubMed Haupt S, Tisdale M, Vincendeau M, Clements MA, Gauthier DT, Lance R, Semmes OJ, Turqueti-Neves A, Noessner E, Leib-Mösch C, Greenwood AD (2011) Human endogenous retrovirus transcription profiles of the kidney and kidney-derived cell lines. J Gen Virol 92:2356–2366PubMed
12.
go back to reference Pichon JP, Bonnaud B, Cleuziat P, Mallet F (2006) Multiplex degenerate PCR coupled with an oligo sorbent array for human endogenous retrovirus expression profiling. Nucleic Acids Res 34:e46PubMedPubMedCentral Pichon JP, Bonnaud B, Cleuziat P, Mallet F (2006) Multiplex degenerate PCR coupled with an oligo sorbent array for human endogenous retrovirus expression profiling. Nucleic Acids Res 34:e46PubMedPubMedCentral
13.
go back to reference Stauffer Y, Theiler G, Sperisen P, Lebedev Y, Jongeneel CV (2004) Digital expression profiles of human endogenous retroviral families in normal and cancerous tissues. Cancer Immun 4:2PubMed Stauffer Y, Theiler G, Sperisen P, Lebedev Y, Jongeneel CV (2004) Digital expression profiles of human endogenous retroviral families in normal and cancerous tissues. Cancer Immun 4:2PubMed
15.
go back to reference Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415–428PubMed Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415–428PubMed
16.
go back to reference Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Chan AT, Schernhammer ES, Giovannucci EL, Fuchs CS (2008) A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst 100:1734–1738PubMedPubMedCentral Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Chan AT, Schernhammer ES, Giovannucci EL, Fuchs CS (2008) A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst 100:1734–1738PubMedPubMedCentral
18.
go back to reference Gimenez J, Montgiraud C, Pichon JP, Bonnaud B, Arsac M, Ruel K, Bouton O, Mallet F (2010) Custom human endogenous retroviruses dedicated microarray identifies self-induced HERV-W family elements reactivated in testicular cancer upon methylation control. Nucleic Acids Res 38:2229–2246PubMedPubMedCentral Gimenez J, Montgiraud C, Pichon JP, Bonnaud B, Arsac M, Ruel K, Bouton O, Mallet F (2010) Custom human endogenous retroviruses dedicated microarray identifies self-induced HERV-W family elements reactivated in testicular cancer upon methylation control. Nucleic Acids Res 38:2229–2246PubMedPubMedCentral
19.
go back to reference Liang Q, Xu Z, Xu R, Wu L, Zheng S (2012) Expression patterns of non-coding spliced transcripts from human endogenous retrovirus HERV-H elements in colon cancer. PLoS ONE 7:e29950PubMedPubMedCentral Liang Q, Xu Z, Xu R, Wu L, Zheng S (2012) Expression patterns of non-coding spliced transcripts from human endogenous retrovirus HERV-H elements in colon cancer. PLoS ONE 7:e29950PubMedPubMedCentral
20.
go back to reference Garnier D, Magnus N, Lee TH, Bentley V, Meehan B, Milsom C, Montermini L, Kislinger T, Rak J (2012) Cancer cells induced to express mesenchymal phenotype release exosome-like extracellular vesicles carrying tissue factor. J Biol Chem 287:43565–43572PubMedPubMedCentral Garnier D, Magnus N, Lee TH, Bentley V, Meehan B, Milsom C, Montermini L, Kislinger T, Rak J (2012) Cancer cells induced to express mesenchymal phenotype release exosome-like extracellular vesicles carrying tissue factor. J Biol Chem 287:43565–43572PubMedPubMedCentral
21.
go back to reference Pergoli L, Favero C, Pfeiffer RM, Tarantini L, Calista D, Cavalleri T, Angelici L, Consonni D, Bertazzi PA, Pesatori AC, Landi MT, Bollati V (2014) Blood DNA methylation, nevi number, and the risk of melanoma. Melanoma Res 24:480–487PubMedPubMedCentral Pergoli L, Favero C, Pfeiffer RM, Tarantini L, Calista D, Cavalleri T, Angelici L, Consonni D, Bertazzi PA, Pesatori AC, Landi MT, Bollati V (2014) Blood DNA methylation, nevi number, and the risk of melanoma. Melanoma Res 24:480–487PubMedPubMedCentral
22.
go back to reference Wang H, Yang B, Geng T, Li B, Dai P, Chen C (2015) Tissue-specific selection of optimal reference genes for expression analysis of anti-cancer drug-related genes in tumor samples using quantitative real-time RT-PCR. Exp Mol Pathol 98:375–381PubMed Wang H, Yang B, Geng T, Li B, Dai P, Chen C (2015) Tissue-specific selection of optimal reference genes for expression analysis of anti-cancer drug-related genes in tumor samples using quantitative real-time RT-PCR. Exp Mol Pathol 98:375–381PubMed
23.
go back to reference Rooney MS, Shukla SA, Wu CJ, Getz G, Hacohen N (2015) Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 160:48–61PubMedPubMedCentral Rooney MS, Shukla SA, Wu CJ, Getz G, Hacohen N (2015) Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 160:48–61PubMedPubMedCentral
24.
go back to reference Lee SH, Kang YJ, Jo JO, Ock MS, Baek KW, Eo J, Lee WJ, Choi YH, Kim WJ, Leem SH, Kim HS, Cha HJ (2014) Elevation of human ERV3-1 env protein expression in colorectal cancer. J Clin Pathol 67:840–844PubMed Lee SH, Kang YJ, Jo JO, Ock MS, Baek KW, Eo J, Lee WJ, Choi YH, Kim WJ, Leem SH, Kim HS, Cha HJ (2014) Elevation of human ERV3-1 env protein expression in colorectal cancer. J Clin Pathol 67:840–844PubMed
25.
go back to reference Ahn K, Kim HS (2009) Structural and quantitative expression analyses of HERV gene family in human tissues. Mol Cells 28:99–103PubMed Ahn K, Kim HS (2009) Structural and quantitative expression analyses of HERV gene family in human tissues. Mol Cells 28:99–103PubMed
26.
go back to reference Alves PM, Lévy N, Stevenson BJ, Bouzourene H, Theiler G, Bricard G, Viatte S, Ayyoub M, Vuilleumier H, Givel JC, Rimoldi D, Speiser DE, Jongeneel CV, Romero PJ, Lévy F (2008) Identification of tumor-associated antigens by large-scale analysis of genes expressed in human colorectal cancer. Cancer Immun 8:11PubMedPubMedCentral Alves PM, Lévy N, Stevenson BJ, Bouzourene H, Theiler G, Bricard G, Viatte S, Ayyoub M, Vuilleumier H, Givel JC, Rimoldi D, Speiser DE, Jongeneel CV, Romero PJ, Lévy F (2008) Identification of tumor-associated antigens by large-scale analysis of genes expressed in human colorectal cancer. Cancer Immun 8:11PubMedPubMedCentral
27.
go back to reference Kim HS, Ahn K, Kim DS (2008) Quantitative expression of the HERV-W env gene in human tissues. Arch Virol 153:1587–1591PubMed Kim HS, Ahn K, Kim DS (2008) Quantitative expression of the HERV-W env gene in human tissues. Arch Virol 153:1587–1591PubMed
28.
go back to reference Pérot P, Mullins CS, Naville M, Bressan C, Hühns M, Gock M, Kühn F, Volff JN, Trillet-Lenoir V, Linnebacher M, Mallet F (2015) Expression of young HERV-H loci in the course of colorectal carcinoma and correlation with molecular subtypes. Oncotarget 6:40095–40111PubMedPubMedCentral Pérot P, Mullins CS, Naville M, Bressan C, Hühns M, Gock M, Kühn F, Volff JN, Trillet-Lenoir V, Linnebacher M, Mallet F (2015) Expression of young HERV-H loci in the course of colorectal carcinoma and correlation with molecular subtypes. Oncotarget 6:40095–40111PubMedPubMedCentral
29.
go back to reference Serafino A, Balestrieri E, Pierimarchi P, Matteucci C, Moroni G, Oricchio E, Rasi G, Mastino A, Spadafora C, Garaci E, Vallebona PS (2009) The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation. Exp Cell Res 315:849–862PubMed Serafino A, Balestrieri E, Pierimarchi P, Matteucci C, Moroni G, Oricchio E, Rasi G, Mastino A, Spadafora C, Garaci E, Vallebona PS (2009) The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation. Exp Cell Res 315:849–862PubMed
30.
go back to reference Balestrieri E, Pica F, Matteucci C, Zenobi R, Sorrentino R, Argaw-Denboba A, Cipriani C, Bucci I, Sinibaldi-Vallebona P (2015) Transcriptional activity of human endogenous retroviruses in human peripheral blood mononuclear cells. Biomed Res Int 2015:164529PubMedPubMedCentral Balestrieri E, Pica F, Matteucci C, Zenobi R, Sorrentino R, Argaw-Denboba A, Cipriani C, Bucci I, Sinibaldi-Vallebona P (2015) Transcriptional activity of human endogenous retroviruses in human peripheral blood mononuclear cells. Biomed Res Int 2015:164529PubMedPubMedCentral
31.
go back to reference Gallois C, Pernot S, Zaanan A, Taieb J (2018) Colorectal cancer: why does side matter? Drugs 78:789–798PubMed Gallois C, Pernot S, Zaanan A, Taieb J (2018) Colorectal cancer: why does side matter? Drugs 78:789–798PubMed
32.
go back to reference Baran B, Mert Ozupek N, Yerli Tetik N, Acar E, Bekcioglu O, Baskin Y (2018) Difference between left-sided and right-sided colorectal cancer: a focused review of literature. Gastroenterol Res 11:264–273 Baran B, Mert Ozupek N, Yerli Tetik N, Acar E, Bekcioglu O, Baskin Y (2018) Difference between left-sided and right-sided colorectal cancer: a focused review of literature. Gastroenterol Res 11:264–273
33.
go back to reference Network CGA (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487:330–337 Network CGA (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487:330–337
34.
go back to reference Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759–767PubMed Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759–767PubMed
35.
go back to reference Worthley DL, Leggett BA (2010) Colorectal cancer: molecular features and clinical opportunities. Clin Biochem Rev 31:31–38PubMedPubMedCentral Worthley DL, Leggett BA (2010) Colorectal cancer: molecular features and clinical opportunities. Clin Biochem Rev 31:31–38PubMedPubMedCentral
36.
go back to reference Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP (1999) CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96:8681–8686PubMedPubMedCentral Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP (1999) CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96:8681–8686PubMedPubMedCentral
37.
go back to reference Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D, Koh H, Simms L, Barker M, Leggett B, Levine J, Kim M, French AJ, Thibodeau SN, Jass J, Haile R, Laird PW (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38:787–793PubMed Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D, Koh H, Simms L, Barker M, Leggett B, Levine J, Kim M, French AJ, Thibodeau SN, Jass J, Haile R, Laird PW (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38:787–793PubMed
38.
go back to reference Balaj L, Lessard R, Dai L, Cho YJ, Pomeroy SL, Breakefield XO, Skog J (2011) Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun 2:180PubMedPubMedCentral Balaj L, Lessard R, Dai L, Cho YJ, Pomeroy SL, Breakefield XO, Skog J (2011) Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun 2:180PubMedPubMedCentral
39.
go back to reference Tyagi R, Li W, Parades D, Bianchet MA, Nath A (2017) Inhibition of human endogenous retrovirus-K by antiretroviral drugs. Retrovirology 14:21PubMedPubMedCentral Tyagi R, Li W, Parades D, Bianchet MA, Nath A (2017) Inhibition of human endogenous retrovirus-K by antiretroviral drugs. Retrovirology 14:21PubMedPubMedCentral
40.
go back to reference MacGowan DJ, Scelsa SN, Imperato TE, Liu KN, Baron P, Polsky B (2007) A controlled study of reverse transcriptase in serum and CSF of HIV-negative patients with ALS. Neurology 68:1944–1946PubMed MacGowan DJ, Scelsa SN, Imperato TE, Liu KN, Baron P, Polsky B (2007) A controlled study of reverse transcriptase in serum and CSF of HIV-negative patients with ALS. Neurology 68:1944–1946PubMed
41.
go back to reference Montesion M, Williams ZH, Subramanian RP, Kuperwasser C, Coffin JM (2018) Promoter expression of HERV-K (HML-2) provirus-derived sequences is related to LTR sequence variation and polymorphic transcription factor binding sites. Retrovirology 15:57PubMedPubMedCentral Montesion M, Williams ZH, Subramanian RP, Kuperwasser C, Coffin JM (2018) Promoter expression of HERV-K (HML-2) provirus-derived sequences is related to LTR sequence variation and polymorphic transcription factor binding sites. Retrovirology 15:57PubMedPubMedCentral
42.
go back to reference Florl AR, Lower R, Schmitz-Drager BJ, Schulz WA (1999) DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br J Cancer 80:1312–1321PubMedPubMedCentral Florl AR, Lower R, Schmitz-Drager BJ, Schulz WA (1999) DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br J Cancer 80:1312–1321PubMedPubMedCentral
43.
go back to reference Hu L, Uzhameckis D, Hedborg F, Blomberg J (2016) Dynamic and selective HERV RNA expression in neuroblastoma cells subjected to variation in oxygen tension and demethylation. APMIS 124:140–149PubMed Hu L, Uzhameckis D, Hedborg F, Blomberg J (2016) Dynamic and selective HERV RNA expression in neuroblastoma cells subjected to variation in oxygen tension and demethylation. APMIS 124:140–149PubMed
44.
go back to reference Ashktorab H, Smoot DT, Farzanmehr H, Fidelia-Lambert M, Momen B, Hylind L, Iacosozio-Dononue C, Carethers JM, Goel A, Boland CR, Giardiello FM (2005) Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans. Int J Cancer 116:914–919PubMedPubMedCentral Ashktorab H, Smoot DT, Farzanmehr H, Fidelia-Lambert M, Momen B, Hylind L, Iacosozio-Dononue C, Carethers JM, Goel A, Boland CR, Giardiello FM (2005) Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans. Int J Cancer 116:914–919PubMedPubMedCentral
45.
go back to reference Nayani R, Ashktorab H, Brim H, Laiyemo AO (2015) Genetic basis for colorectal cancer disparities. Curr Colorectal Cancer Rep 11:408–413PubMedPubMedCentral Nayani R, Ashktorab H, Brim H, Laiyemo AO (2015) Genetic basis for colorectal cancer disparities. Curr Colorectal Cancer Rep 11:408–413PubMedPubMedCentral
Metadata
Title
Human endogenous retroviruses env gene expression and long terminal repeat methylation in colorectal cancer patients
Authors
Maria Dolci
Chiara Favero
Letizia Tarantini
Sonia Villani
Marco Bregni
Lucia Signorini
Alberto Della Valle
Filippo Crivelli
Sarah D’Alessandro
Pasquale Ferrante
Valentina Bollati
Serena Delbue
Publication date
01-04-2020
Publisher
Springer Berlin Heidelberg
Published in
Medical Microbiology and Immunology / Issue 2/2020
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-020-00662-6

Other articles of this Issue 2/2020

Medical Microbiology and Immunology 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine